Alerts will be sent to your verified email
Verify EmailAMBALALSA
|
Ambalal Sarabhai Ent
|
Brooks Laboratories
|
Vaidya Sane Ayur Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
0.01 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
19.11 % | -21.13 % | 8.39 % |
|
5yr average Equity Multiplier
|
2.07 | 1.68 | 1.34 |
|
5yr Average Asset Turnover Ratio
|
0.75 | 0.62 | 1.57 |
|
5yr Avg Net Profit Margin
|
10.89 % | -21.45 % | 3.83 % |
|
Price to Book
|
1.44 | 1.53 | 0.0 |
|
P/E
|
22.06 | 15.37 | 34.92 |
|
5yr Avg Cash Conversion Cycle
|
-37.53 Days | 23.75 Days | -76.76 Days |
|
Inventory Days
|
33.51 Days | 83.11 Days | 11.33 Days |
|
Days Receivable
|
63.69 Days | 80.26 Days | 24.16 Days |
|
Days Payable
|
147.98 Days | 163.46 Days | 116.68 Days |
|
5yr Average Interest Coverage Ratio
|
9.88 | -11.18 | 6.88 |
|
5yr Avg ROCE
|
24.01 % | -11.18 % | 12.91 % |
|
5yr Avg Operating Profit Margin
|
5.29 % | -10.26 % | 7.94 % |
|
5 yr average Debt to Equity
|
0.32 | 0.18 | 0.02 |
|
5yr CAGR Net Profit
|
-30.01 % | -12.45 % | -10.61 % |
|
5yr Average Return on Assets
|
8.69 % | -13.31 % | 6.19 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.36 % | 52.62 % | 66.34 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.59 % | -13.79 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 9.9 % | 0.0 |
|
Ambalal Sarabhai Ent
|
Brooks Laboratories
|
Vaidya Sane Ayur Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
|
Capex
|
Capex
|
-
|
Capex
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|